Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer

NCT00052689 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

88

Enrollment

NIH

Sponsor class

Conditions

Duct Cell Adenocarcinoma of the Pancreas
Stage IV Pancreatic Cancer

Interventions

DRUG: bortezomib
DRUG: gemcitabine hydrochloride

Sponsor

National Cancer Institute (NCI)